1. Home
  2. IMMP vs CRWS Comparison

IMMP vs CRWS Comparison

Compare IMMP & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

N/A

Current Price

$3.60

Market Cap

31.5M

Sector

Health Care

ML Signal

N/A

Logo Crown Crafts Inc

CRWS

Crown Crafts Inc

N/A

Current Price

$2.41

Market Cap

29.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMP
CRWS
Founded
1987
1957
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Textiles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
29.4M
IPO Year
2012
1994

Fundamental Metrics

Financial Performance
Metric
IMMP
CRWS
Price
$3.60
$2.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 303.6K
80.4K
Earning Date
09-01-2026
11-11-2026
Dividend Yield
N/A
★ 4.94%
EPS Growth
N/A
★ 118.89
EPS
N/A
★ 0.17
Revenue
N/A
★ $70,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$14.29
Revenue Growth
N/A
★ 6.51
52 Week Low
$0.26
$2.35
52 Week High
$5.36
$3.14

Technical Indicators

Market Signals
Indicator
IMMP
CRWS
Relative Strength Index (RSI) 67.55 25.96
Support Level $2.65 N/A
Resistance Level $5.36 $2.61
Average True Range (ATR) 0.22 0.07
MACD 0.11 -0.00
Stochastic Oscillator 64.73 0.00

Price Performance

Historical Comparison
IMMP
CRWS

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: